The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.131.6.695

The authors present experimental evidence to support the hypothesis that 2-phenylethylamine (PEA) and its metabolites modulate affective behavior. Values for the urinary excretion of PEA were lower for 71 percent of a group of depressed patients than the lowest values obtained from control subjects, which suggests that a large percentage of endogenous depressions may be due to a deficit of PEA in the brain. Animal studies indicate that an increase in the levels of PEA in the brain may be partly responsible for the elation induced by marijuana and for the therapeutic action of antidepressant agents.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.